Clinical Trials Arena on MSN

Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...